Skip to main content
California Medicine logoLink to California Medicine
. 1953 Feb;78(2):91–94.

NEWER THERAPY FOR LEUKEMIA, POLYCYTHEMIA, AND LYMPHOMA

Arthur A Marlow, Grant R Bartlett
PMCID: PMC1521693  PMID: 13019601

Abstract

X-radiation remains the treatment of choice in most cases of leukemia and lymphoma, but new agents are playing an increasing role in therapy. Radioactive phosphorus does not produce radiation sickness and results with it are comparable to those of x-ray therapy in chronic leukemia. Urethane and nitrogen mustard may produce remissions in patients with chronic leukemia who have become resistant to radiation. Triethylene melamine may be administered orally with nitrogen mustard-like effects and is undergoing further trial. Aminopterin, ACTH and cortisone often cause short remissions in acute leukemia. Urethane is the best treatment available for multiple myeloma. Polycythemia vera is well controlled by radioactive phosphorus combined with venesection. Nitrogen mustard is often effective and triethylene melamine shows promise in Hodgkin's disease. Antianemic substances such as iron and liver extract are of no value in the treatment of anemia caused by leukemia, lymphoma and myeloma.

Full text

PDF
91

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOCK M., JACOBSON L. O. Management of the lymphomas. Med Clin North Am. 1951 Jan;35(1):93–110. [PubMed] [Google Scholar]
  2. OSGOOD E. E. Titrated, regularly spaced radioactive phosphorus or spray roentgen therapy of leukemias. AMA Arch Intern Med. 1951 Mar;87(3):329–348. doi: 10.1001/archinte.1951.03810030002001. [DOI] [PubMed] [Google Scholar]
  3. PILLERS E. M. K., BURCHENAL J. H., ELIEL L. P., PEARSON O. H. Resistance to corticotropin, cortisone, and folic acid antagonists in leukemia. J Am Med Assoc. 1952 Mar 22;148(12):987–994. doi: 10.1001/jama.1952.02930120009003. [DOI] [PubMed] [Google Scholar]
  4. ROSS J. F., EBAUGH F. G., Jr Current trends in the management of the leukemias and the malignant lymphomas. Med Clin North Am. 1951 Sep;35(5):1381–1401. [PubMed] [Google Scholar]
  5. SILVERBERG J. H., DAMESHEK W. Use of triethylene melamine in treatment of leukemia and leukosarcoma. J Am Med Assoc. 1952 Mar 22;148(12):1015–1021. doi: 10.1001/jama.1952.02930120037009. [DOI] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES